Tuesday, August 4, 2026

How Google’s TurboQuant AI Compression Shocked Memory Stocks: A Deep Dive

Google's TurboQuant technology caused a selloff in memory stocks, impacting major players in both Asia and the U.S. markets.

Destroyer Named After Kim Il-sung’s Comrade Highlights North Korea’s Propaganda Strategy

North Korea's new destroyer is named after guerrilla hero Choe Hyon, emphasizing loyalty to Kim Jong Un and revolutionary legacy.

TRUMP’S $90,000,000,000 MISTAKE: Supreme Court Could Force US To Refund ALL Reciprocal Tariffs

Trump claims losing the tariff lawsuit could cost over $2 trillion, stressing national security and legality concerns as the Supreme Court deliberates.

Health

Huawei Unveils OpenPangu 2.0 Pro: Is This the Future of AI with 505 Billion Parameters?

Huawei accelerates its AI ecosystem expansion by revealing the source of its massive AI model with over 500 billion parameters.

AI-Driven Preclinical Platform: Revolutionizing Infectious Disease Treatment and Vaccine Development by 2030

An AI-based digital preclinical platform is being developed to expedite the creation of treatments and vaccines for emerging infectious diseases.

Revolutionizing Stroke Treatment: JLK’s AI Solution in 22 Hospitals

JLK, a medical AI firm, initiates a large-scale clinical study on stroke AI imaging solutions across 22 hospitals in Korea.

What Makes QP101 the Next Big Breakthrough in Cancer Treatment?

QP101, a next-gen antibody-drug conjugate by Curient, is highlighted as a notable drug development strategy by AACR.

Hong Seong-ho of Seoul St. Mary’s Hospital Becomes First in Asia-Pacific to Perform 1,000 Single-Port Robotic Urologic Surgeries

A South Korean medical team achieved 1,000 single-port robotic surgeries in urology, led by Professor Hong Seong-ho.
Latest

Eli Lilly’s New Weight Loss Pill Foundayo: A Game Changer in the GLP-1 Market?

The FDA has approved Eli Lilly's oral obesity drug Foundayo, enhancing competition in the weight loss market with flexible dosing.

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

AITRICS Achieves MDSAP Certification: What This Means for Global Medical Device Standards

AITRICS gains MDSAP certification, enhancing its global market entry and demonstrating compliance with international quality standards.

SANDRO Dual 2026: The Next Big Thing in Laser Hair Removal Approved by Japan and Taiwan

Wontech's SANDRO Dual 2026 laser device gains certifications in Japan and Taiwan, enhancing its global market presence in cosmetic procedures.

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

Seragem’s Groundbreaking Hybrid Simulation Technology: What You Need to Know About Its Impact on Medical Devices

Ceragem Clinical's human simulation model enhances healthcare device efficiency, published in Annals of Biomedical Engineering.

Samsung Biologics Wins “Sustainability Leadership” at CDMO Awards: What This Means for the Future of Biopharma

Samsung Biologics wins the Sustainability Leadership award, marking a 13-year streak and highlighting its commitment to sustainable practices.

How Long-Term Use of Anticholinergic Medications Increases Fracture Risk by 65% in Seniors

A study reveals older adults on long-term medications face a 43% higher fracture risk, emphasizing the danger of anticholinergic drugs.

KIMES 2026: Record-Breaking Medical Expo Achieves 2.3 Trillion USD in Domestic Deals!

KIMES 2026 set attendance records with 75,003 visitors, generating 1.5 billion USD in domestic consultations and 450 million USD in exports.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

Celltrion Launches Omlyclo in Brazil: How This First Mover is Revolutionizing Autoimmune Treatment

Celltrion launched Omlyclo in Brazil, aiming to boost market penetration and strengthen ties with local medical professionals.

Samsung Biologics America Achieves Record Profit: What This Means for Global Expansion in 2026

Samsung Biologics America reports record profits, showcasing its successful global expansion strategy despite previous revenue dips.

Classys Unveils Aggressive Growth Strategy at AAD 2026: What’s Next for the U.S. Market?

Classys reveals its growth strategy for the U.S. market at AAD 2026, showcasing innovative products and emphasizing clinical efficacy.

Rokit Healthcare’s Groundbreaking Kidney Regeneration Patent: What It Means for Patients and the Market

Rokit Healthcare secures a U.S. patent for kidney regeneration, aiming to revolutionize treatment and collaboration with Harvard Medical School.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.